Furthermore, the AXL signaling pathway not only contributes to the progression and resistance phenotypes of HCC [19], but also exerts suppressive effects on both adaptive and innate immune responses against malignancies [20,21]. The gene discussed is AXL; the disease is hepatocellular carcinoma.